Blend dossier · component evidence, sources, and live market
TRI-BLEND
3-compound blend blend evidence is component-scoped 6 cited studies 3 live vendors
A vendor-sold three-compound repair blend. This page treats TRI-BLEND as a market product while keeping research claims attached to the individual ingredients actually studied.
Vendor links are temporarily offline while we review our referral and linking policies. Listings remain for price transparency.
first-party prices captured 8m ago
| # | Vendor | Published product / formula | COA | Total | |
|---|---|---|---|---|---|
| 1 | Nextech Laboratories | TRI BLEND (BPC-157/TB500/KPV) (10mg/10mg/10mg)BLENDcaptured 6m ago | 2 at lab | $99.99 | |
| 2 | Atomik Labz | TRI-BLEND (BPC-157/TB-500/KPV) 10mg 10mg 10mgBLENDcaptured 7m ago | publishes | $129.00 | |
| 3 | Solution Peptides | TRI-BLEND (BPC-157 / TB-500 / KPV) 10mg 10mg 10mgBLENDcaptured 5m ago | publishes | $129.00 |
- Are research peptides safe? What the evidence does and doesn't showLimited evidence
"Are peptides safe?" has no single answer. The compounds sold as research peptides sit at very different points on the evidence scale, from large randomized human trials for a few to animal-only data for many.
Read the full review → - What the research says about BPC-157 and tissue repairPreclinical only
BPC-157 (body protection compound-157) is a peptide studied mainly in animal and in-vitro models for tissue repair; the published work is overwhelmingly preclinical.
Read the full review → - What the research says about TB-500 and thymosin β4Preclinical only
"TB-500" is sold as a synthetic peptide related to thymosin β4 (Tβ4); the peer-reviewed literature studies thymosin β4 itself, and it is overwhelmingly preclinical — animal and in-vitro models.
Read the full review → - What the research says about KPVPreclinical only
KPV is the C-terminal tripeptide (lysine-proline-valine) of alpha-melanocyte-stimulating hormone (alpha-MSH), studied for anti-inflammatory and antimicrobial properties.
Read the full review →
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing PubMed ↗
There is a current need for a therapy that can alleviate the social and economic burden that presents itself with debilitating and recurring musculoskeletal soft tissue injuries and disorders. Currently, several therapies are emerging an…
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing PubMed ↗
Significance: The antiulcer peptide, stable gastric pentadecapeptide BPC 157 (previously employed in ulcerative colitis and multiple sclerosis trials, no reported toxicity (LD1 not achieved)), is reviewed, focusing on the particular skin…
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review PubMed ↗
Background: Body protection compound-157 (BPC-157) is a naturally occurring gastric peptide that promotes mucosal integrity and homeostasis. Preclinical studies show its potential for promoting healing in musculoskeletal injuries such as…
- Thymosin beta-4 denotes new directions towards developing prosperous anti-aging regenerative therapies PubMed ↗
Our dream of defeating the processes of organ damage and aging remains a challenge scientists pursued for hundreds of years. Although the goal is to successfully treat the body as a whole, steps towards regenerating individual organs are…
- Cardioprotection by Thymosin Beta 4 PubMed ↗
Treatment with thymosin beta 4 (Tβ4) reduces infarct volume and preserves cardiac function in preclinical models of cardiac ischemic injury. These effects stem in part from decreased infarct size, but additional benefits are likely due t…
- Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids PubMed ↗
The developmental origin of Alzheimer disease (AD) has been proposed but is arguably debated. Here, we developed cerebral organoids from induced pluripotent stem cells (iPSCs) with mutations in amyloid precursor protein (APP) associated …
These studies concern individual components, not the named blend as a finished intervention. They do not establish that combining the ingredients reproduces any result.
The most-searched repair peptide — and, by reputation, the most counterfeited.
Thymosin Beta-4 fragment; the classic BPC-157 stack partner.
A short α-MSH-derived tripeptide studied in research contexts for gut and inflammatory-response models; a common add-on in repair stacks.